Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Nebraska
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Swiss Cancer Institute